Onesource Specialty Pharma Limited (ONESOURCE) reported revenue of ₹449 Cr and net profit of ₹25.00 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
ONESOURCE fundamentals, Fundamental score 32/100
The statements below are read from Onesource Specialty Pharma Limited’s filed results, 10 filed quarters and 6 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Jul 27, 2026 · audited
Sales CAGR · 3Y+231.6%FY22 → FY25
Sales CAGR · 4Y+81.2%FY21 → FY25
PAT CAGR · 3Y—FY22 → FY25
PAT CAGR · 4Y—FY21 → FY25
Price · 1Y−18.2%EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Sep2023
Mar2024
Jun2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
34.0
73.0
292
393
426
327
376
290
428
449
+37.2%
72.0
76.0
228
249
243
239
269
273
336
326
+36.4%
Operating profit
-38.0
-3.00
64.0
143
183
88.5
106
17.3
91.9
123
+39.4%
OPM %
-111.8%
-4.1%
21.9%
36.5%
42.8%
27.0%
28.3%
6.0%
21.5%
27.5%
+0.4 pp
Other income
-32.0
3.00
-1.00
5.39
2.89
5.27
3.04
4.63
2.09
3.80
-27.8%
Interest
25.0
20.0
42.0
45.8
33.4
27.5
34.0
38.2
22.5
30.8
+12.1%
Depreciation
18.0
20.0
68.0
68.8
68.5
67.8
69.8
69.6
71.8
71.7
+5.8%
Profit before tax
-114
-40.0
-47.0
-66.5
83.5
-4.40
5.74
-93.0
-0.29
20.3
n/m
Tax %
n/a (loss)
n/a (loss)
n/a (loss)
n/a (loss)
-18.4%
n/a (loss)
-82.6%
n/a (loss)
n/a (loss)
-23.2%
—
Net profit
-114
-40.0
-6.00
-68.8
98.2
-0.19
10.5
-88.7
4.60
25.0
n/m
EPS (₹)
—
—
—
-6.31
8.61
-0.02
0.92
-7.74
0.40
2.18
n/m
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters
Revenue & net profit trend
last 10 quarters
RevenueNet profit
Revenue & net profit — Consolidated10 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±4.5%· EPS surprise: no estimates source· 3 earlier quarters have no dated filing on record
